Loading data
ENSCNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 5.07 m USD | 5.21 m USD | 2.23 m USD | 2.52 m USD | 3.53 m USD |
| Research and development expense | 10.38 m USD | 7.22 m USD | 7.59 m USD | 19.84 m USD | 4.69 m USD |
| Operating profit | -10.24 m USD | -6.73 m USD | -10.72 m USD | -24.22 m USD | -19.87 m USD |
| Interest expense | — | — | 353.95 k USD | 109.53 k USD | 1.3 m USD |
| Net income (reported basis) | -10.18 m USD | 7.99 m USD | 10.63 m USD | 25.09 m USD | -29.15 m USD |
| Net income attributable to common shareholders | -10.18 m USD | -7.99 m USD | -10.63 m USD | -25.09 m USD | -29.89 m USD |
| Basic earnings per share | -3.98 USD/share | -11.45 USD/share | -70.4 USD/share | -139.42 USD/share | -29.64 USD/share |
| Diluted earnings per share | -3.98 USD/share | -11.45 USD/share | -70.4 USD/share | -139.42 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.